Moderna makes the case for boosters
Moderna on Wednesday released its own analysis of various studies, making the case that the company's original vaccine appears to generate the strongest protection among the three currently authorized vaccines, but also saying people who got their vaccine will also need a booster six months later.
Like Pfizer, Moderna is requesting authorization for a booster dose six months after the primary vaccination based on evidence that boosters are safe and generate immune response, and based on newly published data from its phase 3 trial showing a lower risk of breakthrough infections among people vaccinated eight months ago compared to people vaccinated 13 months ago.
Unlike Pfizer, Moderna’s third booster will be a half-dose. Moderna says its data shows that boosting with a half-shot seems to generate more than enough immune response.
-ABC News' Sony Salzman







